Axogen Inc
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the quarter ended March 31, 2024, our Section 16 officers and directors adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) of Regulation S-K as noted below:
| Trading Arrangement | |||||
|---|---|---|---|---|---|
| Name and Title · Action · Adoption Date · Rule 10b5-1* · Non-Rule 10b5-1** · Aggregate Number of Securities to be Sold · Expiration Date | |||||
| Karen Zaderej | Adopt | 3/8/2024 | X | 740,000 | 12/31/2024 |
| *Intended to satisfy the affirmative defense of Rule 10b5-1(c) | |||||
| ** Not intended to satisfy the affirmative defense of Rule 10b5-1(c) | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.